BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8393098)

  • 1. Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group.
    Shepherd FA; Ginsberg RJ; Haddad R; Feld R; Sagman U; Evans WK; DeBoer G; Maki E
    J Clin Oncol; 1993 Aug; 11(8):1592-7. PubMed ID: 8393098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
    Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current perspectives in the management of small cell lung cancer].
    Fujita J; Saijo N
    Gan No Rinsho; 1985 Jan; 31(1):1-19. PubMed ID: 2984443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study.
    Shepherd FA; Ginsberg RJ; Patterson GA; Evans WK; Feld R
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):177-86. PubMed ID: 2536868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
    Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
    J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion.
    Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Saijo N; Nishiwaki Y
    J Thorac Oncol; 2008 Jul; 3(7):723-7. PubMed ID: 18594317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
    Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y
    J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.
    Kubota K; Hida T; Ishikura S; Mizusawa J; Nishio M; Kawahara M; Yokoyama A; Imamura F; Takeda K; Negoro S; Harada M; Okamoto H; Yamamoto N; Shinkai T; Sakai H; Matsui K; Nakagawa K; Shibata T; Saijo N; Tamura T;
    Lancet Oncol; 2014 Jan; 15(1):106-13. PubMed ID: 24309370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis in limited disease (LD) small cell lung cancer (SCLC) patients according to status performance, local extension of lesions, type of treatment and the completeness of staging].
    Remiszewski P; Roszkowski-Sliz K; Wiatr E; Roszkowska-Sliz B; Zych J; Kurzyna M; Jodkiewicz Z; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 2003; 71(3-4):139-47. PubMed ID: 14587419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.
    Shepherd FA; Crowley J; Van Houtte P; Postmus PE; Carney D; Chansky K; Shaikh Z; Goldstraw P;
    J Thorac Oncol; 2007 Dec; 2(12):1067-77. PubMed ID: 18090577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.
    De Ruysscher D; Bremer RH; Koppe F; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Pitz C; Simons J; ten Velde G; Dohmen J; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Dehing C; Pijls M; Minken A; Lambin P
    Radiother Oncol; 2006 Sep; 80(3):307-12. PubMed ID: 16949169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
    Simon GR; Turrisi A;
    Chest; 2007 Sep; 132(3 Suppl):324S-339S. PubMed ID: 17873178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study.
    Aisner J; Goutsou M; Maurer LH; Cooper R; Chahinian P; Carey R; Skarin A; Slawson R; Perry MC; Green MR
    J Clin Oncol; 1992 Aug; 10(8):1230-6. PubMed ID: 1321892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group.
    Johnson DH; Bass D; Einhorn LH; Crawford J; Perez CA; Bartolucci A; Omura GA; Greco FA
    J Clin Oncol; 1993 Jul; 11(7):1223-9. PubMed ID: 8391064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung.
    Shepherd FA; Evans WK; Feld R; Young V; Patterson GA; Ginsberg R; Johansen E
    J Clin Oncol; 1988 May; 6(5):832-8. PubMed ID: 2835443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
    Yue X; Zang QC
    Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.